Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF

By rosaguerrero • June 21, 2022

Chapman B, Hellkamp AS, Thomas LE, Albert NM, Butler J, Patterson JH, Hernandez AF, Williams FB, Shen X, Spertus JA, Fonarow GC, DeVore AD. Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF. J Am Heart Assoc. 2022 Jun 20;11(12):e022889. doi: 10.1161/JAHA.121.022889. Epub ahead of print. PMID: 35722989; PMCID: PMC9238653.

Tags: angiotensin receptor neprilysin inhibitor, Cardiology/Epi, heart failure, population groups, Publications, registries, sacubitril/valsartan

GLP-1 Receptor Agonist in Non-obese Patients with Type-2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction

Khadke S, Kumar A, Bhatti A, Dani SS, Al-Kindi S, Nasir K, Virani SS, Upadhyay J, Garcia-Banigan DC, Abraham S, Husami R, Kong Y, Labib[...]

Resolution of ventricular tachycardia and cardiac inflammation following treatment in chronic Chagas disease

Malik A, Jiang M, Muñoz G, Meymandi S, Bradfield JS, Hayase J. Resolution of ventricular tachycardia and cardiac inflammation following treatment in chronic Chagas disease.[...]

Transcatheter Edge-to-Edge Repair in Patients With Complex Tricuspid Valve Anatomy

Adams DH, Tang GHL, Whisenant BK, Kodali SK, Singh GD, Fam NP, Kar S, Price MJ, Spies C, Schwartz JG, Makkar RR, Tadros P, Asgar[...]